Literature DB >> 24247723

Proteogenomic analysis reveals unanticipated adaptations of colorectal tumor cells to deficiencies in DNA mismatch repair.

Patrick J Halvey1, Xiaojing Wang, Jing Wang, Ajaz A Bhat, Punita Dhawan, Ming Li, Bing Zhang, Daniel C Liebler, Robbert J C Slebos.   

Abstract

A growing body of genomic data on human cancers poses the critical question of how genomic variations translate to cancer phenotypes. We used standardized shotgun proteomics and targeted protein quantitation platforms to analyze a panel of 10 colon cancer cell lines differing by mutations in DNA mismatch repair (MMR) genes. In addition, we performed transcriptome sequencing (RNA-seq) to enable detection of protein sequence variants from the proteomic data. Biologic replicate cultures yielded highly consistent proteomic inventories with a cumulative total of 6,513 protein groups with a protein false discovery rate of 3.17% across all cell lines. Networks of coexpressed proteins with differential expression based on MMR status revealed impact on protein folding, turnover and transport, on cellular metabolism and on DNA and RNA synthesis and repair. Analysis of variant amino acid sequences suggested higher stability of proteins affected by naturally occurring germline polymorphisms than of proteins affected by somatic protein sequence changes. The data provide evidence for multisystem adaptation to MMR deficiency with a stress response that targets misfolded proteins for degradation through the ubiquitin-dependent proteasome pathway. Enrichment analysis suggested epithelial-to-mesenchymal transition in RKO cells, as evidenced by increased mobility and invasion properties compared with SW480. The observed proteomic profiles demonstrate previously unknown consequences of altered DNA repair and provide an expanded basis for mechanistic interpretation of MMR phenotypes.

Entities:  

Mesh:

Year:  2013        PMID: 24247723      PMCID: PMC3896054          DOI: 10.1158/0008-5472.CAN-13-2488

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  41 in total

1.  Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype.

Authors:  Venkateshwar G Keshamouni; George Michailidis; Catherine S Grasso; Shalini Anthwal; John R Strahler; Angela Walker; Douglas A Arenberg; Raju C Reddy; Sudhakar Akulapalli; Victor J Thannickal; Theodore J Standiford; Philip C Andrews; Gilbert S Omenn
Journal:  J Proteome Res       Date:  2006-05       Impact factor: 4.466

2.  Differential nonsense mediated decay of mutated mRNAs in mismatch repair deficient colorectal cancers.

Authors:  Jamila El-Bchiri; Olivier Buhard; Virginie Penard-Lacronique; Gilles Thomas; Richard Hamelin; Alex Duval
Journal:  Hum Mol Genet       Date:  2005-07-06       Impact factor: 6.150

3.  Methods for peptide and protein quantitation by liquid chromatography-multiple reaction monitoring mass spectrometry.

Authors:  Haixia Zhang; Qinfeng Liu; Lisa J Zimmerman; Amy-Joan L Ham; Robbert J C Slebos; Jamshedur Rahman; Takefume Kikuchi; Pierre P Massion; David P Carbone; Dean Billheimer; Daniel C Liebler
Journal:  Mol Cell Proteomics       Date:  2011-02-27       Impact factor: 5.911

4.  The consensus coding sequences of human breast and colorectal cancers.

Authors:  Tobias Sjöblom; Siân Jones; Laura D Wood; D Williams Parsons; Jimmy Lin; Thomas D Barber; Diana Mandelker; Rebecca J Leary; Janine Ptak; Natalie Silliman; Steve Szabo; Phillip Buckhaults; Christopher Farrell; Paul Meeh; Sanford D Markowitz; Joseph Willis; Dawn Dawson; James K V Willson; Adi F Gazdar; James Hartigan; Leo Wu; Changsheng Liu; Giovanni Parmigiani; Ben Ho Park; Kurtis E Bachman; Nickolas Papadopoulos; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu
Journal:  Science       Date:  2006-09-07       Impact factor: 47.728

5.  A bioinformatics workflow for variant peptide detection in shotgun proteomics.

Authors:  Jing Li; Zengliu Su; Ze-Qiang Ma; Robbert J C Slebos; Patrick Halvey; David L Tabb; Daniel C Liebler; William Pao; Bing Zhang
Journal:  Mol Cell Proteomics       Date:  2011-03-09       Impact factor: 5.911

Review 6.  Cancer genes and the pathways they control.

Authors:  Bert Vogelstein; Kenneth W Kinzler
Journal:  Nat Med       Date:  2004-08       Impact factor: 53.440

7.  DLD-1 and HCT-15 cell lines derived separately from colorectal carcinomas have totally different chromosome changes but the same genetic origin.

Authors:  T R Chen; C S Dorotinsky; L J McGuire; M L Macy; R J Hay
Journal:  Cancer Genet Cytogenet       Date:  1995-06

8.  The impact of microsatellite instability on the molecular phenotype of colorectal tumors.

Authors:  Yuriko Mori; Florin M Selaru; Fumiaki Sato; Jing Yin; Lisa A Simms; Yan Xu; Andreea Olaru; Elena Deacu; Suna Wang; Jennifer M Taylor; Joanne Young; Barbara Leggett; Jeremy R Jass; John M Abraham; David Shibata; Stephen J Meltzer
Journal:  Cancer Res       Date:  2003-08-01       Impact factor: 12.701

9.  Proteomic consequences of a single gene mutation in a colorectal cancer model.

Authors:  Patrick J Halvey; Bing Zhang; Robert J Coffey; Daniel C Liebler; Robbert J C Slebos
Journal:  J Proteome Res       Date:  2011-12-13       Impact factor: 4.466

10.  Colorectal cancers with microsatellite instability display mRNA expression signatures characteristic of increased immunogenicity.

Authors:  Ayan Banerjea; Shafi Ahmed; Rebecca E Hands; Fei Huang; Xia Han; Peter M Shaw; Roger Feakins; Stephen A Bustin; Sina Dorudi
Journal:  Mol Cancer       Date:  2004-08-06       Impact factor: 27.401

View more
  20 in total

Review 1.  Methods, Tools and Current Perspectives in Proteogenomics.

Authors:  Kelly V Ruggles; Karsten Krug; Xiaojing Wang; Karl R Clauser; Jing Wang; Samuel H Payne; David Fenyö; Bing Zhang; D R Mani
Journal:  Mol Cell Proteomics       Date:  2017-04-29       Impact factor: 5.911

2.  Association of C722T polymorphism in XRCC3 gene with larynx cancer: a meta-analysis.

Authors:  Dong Li; Hui-Hua You; Yuan-Jing Jia; Jian-Dong Guo; Huan-Le Du
Journal:  Tumour Biol       Date:  2014-02-13

3.  Leveraging the complementary nature of RNA-Seq and shotgun proteomics data.

Authors:  Xiaojing Wang; Qi Liu; Bing Zhang
Journal:  Proteomics       Date:  2014-11-17       Impact factor: 3.984

4.  Identification and Characterization of Human Proteoforms by Top-Down LC-21 Tesla FT-ICR Mass Spectrometry.

Authors:  Lissa C Anderson; Caroline J DeHart; Nathan K Kaiser; Ryan T Fellers; Donald F Smith; Joseph B Greer; Richard D LeDuc; Greg T Blakney; Paul M Thomas; Neil L Kelleher; Christopher L Hendrickson
Journal:  J Proteome Res       Date:  2016-12-12       Impact factor: 4.466

5.  Onco-proteogenomics: cancer proteomics joins forces with genomics.

Authors:  Javier A Alfaro; Ankit Sinha; Thomas Kislinger; Paul C Boutros
Journal:  Nat Methods       Date:  2014-11       Impact factor: 28.547

6.  Quantitative Profiling of Protein Tyrosine Kinases in Human Cancer Cell Lines by Multiplexed Parallel Reaction Monitoring Assays.

Authors:  Hye-Jung Kim; De Lin; Hyoung-Joo Lee; Ming Li; Daniel C Liebler
Journal:  Mol Cell Proteomics       Date:  2015-12-02       Impact factor: 5.911

7.  Integrated Transcriptomic-Proteomic Analysis Using a Proteogenomic Workflow Refines Rat Genome Annotation.

Authors:  Dhirendra Kumar; Amit Kumar Yadav; Xinying Jia; Jason Mulvenna; Debasis Dash
Journal:  Mol Cell Proteomics       Date:  2015-11-11       Impact factor: 5.911

8.  Quantitative Proteomics of the Cancer Cell Line Encyclopedia.

Authors:  David P Nusinow; John Szpyt; Mahmoud Ghandi; Christopher M Rose; E Robert McDonald; Marian Kalocsay; Judit Jané-Valbuena; Ellen Gelfand; Devin K Schweppe; Mark Jedrychowski; Javad Golji; Dale A Porter; Tomas Rejtar; Y Karen Wang; Gregory V Kryukov; Frank Stegmeier; Brian K Erickson; Levi A Garraway; William R Sellers; Steven P Gygi
Journal:  Cell       Date:  2020-01-23       Impact factor: 41.582

9.  Precise characterization of KRAS4b proteoforms in human colorectal cells and tumors reveals mutation/modification cross-talk.

Authors:  Ioanna Ntai; Luca Fornelli; Caroline J DeHart; Josiah E Hutton; Peter F Doubleday; Richard D LeDuc; Alexandra J van Nispen; Ryan T Fellers; Gordon Whiteley; Emily S Boja; Henry Rodriguez; Neil L Kelleher
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-02       Impact factor: 11.205

Review 10.  Proteogenomics: Integrating Next-Generation Sequencing and Mass Spectrometry to Characterize Human Proteomic Variation.

Authors:  Gloria M Sheynkman; Michael R Shortreed; Anthony J Cesnik; Lloyd M Smith
Journal:  Annu Rev Anal Chem (Palo Alto Calif)       Date:  2016-03-30       Impact factor: 10.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.